Logo
x

Search category

Subscribe Now

P-I Trial

Celltrion Plans to Initiate P-I Trial for its CT-P41 (biosimilar- denosumab) in September 2020

Celltrion Plans to Initiate P-I Trial for its CT-P41 (biosimilar- denosumab) in September 2020

  • August 14, 2020
Xspray Pharma Reports Positive P-I Trial Results of HyNap-Dasa for the Treatment of Chronic Myeloid Leukemia (CML)

Xspray Pharma Reports Positive P-I Trial Results of HyNap-Dasa for the Treatment of Chronic Myeloid Leukemia (CML)

  • September 10, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.